Plerixafor
NDC 31722-373, Plerixafor, injection, solution, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-373
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217560
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-373 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PLERIXAFOR24 mg/1.2mL
Pharmacologic classes
Hematopoietic Stem Cell Mobilizer [EPC]; Increased Hematopoietic Stem Cell Mobilization [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-373-31 | 31722037331 | 1 VIAL, SINGLE-USE in 1 CARTON (31722-373-31) / 1.2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bb8e1167-8378-4e73-9bcb-d69093ec829b
Use it
Look up 31722-373 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-373 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-373. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.